CLDX — CELLDEX THERAPEUTICS INC NEW

Ownership history in PRUDENTIAL FINANCIAL INC  ·  9 quarters on record

This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in CELLDEX THERAPEUTICS INC NEW (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q4)
Avg. % of fund
0.0%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 8,809 -59,662 -87.1% 0.00% $228K $25.87
2024 Q3 REDUCED 68,471 -4,430 -6.1% 0.00% $2.3M $33.99
2024 Q2 ADDED 72,901 +58,815 +417.5% 0.00% $2.7M $37.01
2024 Q1 REDUCED 14,086 -43,515 -75.5% 0.00% $591K $41.97
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CLDX price (monthly, adj. close)

Other funds also holding CLDX

As of 2025 Q4 — sorted by position size

Kynam Capital Management, LP 3Y 10.31% Elmind Capital, LP 6.93% Commodore Capital LP 3Y 4.64% 5AM Venture Management, LLC 3Y 4.25% Propel Bio Management, LLC 3.58% GordonMD Global Investments LP 3.32% Novo Holdings A/S 3Y 7Y 2.53% TSP Capital Management Group, LLC 3Y 7Y 2.49% Eversept Partners, LP 3Y 7Y 1.96% Bellevue Group AG 3Y 7Y 1.86%
← Back to PRUDENTIAL FINANCIAL INC Holdings